fluoromisonidazole has been researched along with Colorectal Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, H; Jiang, HJ; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ | 1 |
Carlin, SD; Gönen, M; Grkovski, M; Humm, JL; Lee, NY; Nehmeh, SA; Schöder, H; Schwartz, J; Zanzonico, PB | 1 |
De Bruycker, S; Pauwels, P; Staelens, S; Stroobants, S; Van den Wyngaert, T; Vangestel, C; Wouters, A; Wyffels, L | 1 |
Carlin, S; Ling, CC; Lorenzen, S; O'Donoghue, JA; Oehler, C; Russell, J; Zanzonico, P | 1 |
4 other study(ies) available for fluoromisonidazole and Colorectal Cancer
Article | Year |
---|---|
Topics: Animals; Colorectal Neoplasms; Disease Models, Animal; Female; Humans; Liver Neoplasms; Mice; Misonidazole; Neoplasm Invasiveness; Positron-Emission Tomography; Radiographic Image Enhancement; Random Allocation; Sensitivity and Specificity; Xenograft Model Antitumor Assays | 2019 |
Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.
Topics: Algorithms; Animals; Carcinoma, Squamous Cell; Cohort Studies; Colorectal Neoplasms; Head and Neck Neoplasms; HT29 Cells; Humans; Hypoxia; Image Processing, Computer-Assisted; Misonidazole; Neoplasm Transplantation; Perfusion; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reproducibility of Results; Retrospective Studies; ROC Curve | 2016 |
Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice, Nude; Misonidazole; Positron-Emission Tomography; Reproducibility of Results; Xenograft Model Antitumor Assays | 2016 |
18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Colorectal Neoplasms; Female; HT29 Cells; Humans; Mice; Mice, Nude; Misonidazole; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Xanthones | 2011 |